Indivior PLC (INDV) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.612x

Based on the latest financial reports, Indivior PLC (INDV) has a cash flow conversion efficiency ratio of -0.612x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX158.00 Million ≈ $19.22K USD) by net assets (GBX-258.00 Million ≈ $-31.39K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Indivior PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Indivior PLC - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Indivior PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Indivior PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indivior PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kolon Corp KO:002025	0.031x
Smithson Investment Trust PLC LSE:SSON	0.000x
Neonode Inc NASDAQ:NEON	-0.057x
MetaLabs Co Ltd KO:090370	0.018x
Lancashire Holdings Ltd LSE:LRE	0.018x
Dyandra Media International PT JK:DYAN	-0.037x
Trivarx Ltd AU:TRI	-0.023x
Assura PLC LSE:AGR	0.042x

Annual Cash Flow Conversion Efficiency for Indivior PLC (2011–2024)

The table below shows the annual cash flow conversion efficiency of Indivior PLC from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Indivior PLC market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX-348.00 Million ≈ $-42.34K	GBX36.00 Million ≈ $4.38K	-0.103x	-100.36%
2023-12-31	GBX-11.00 Million ≈ $-1.34K	GBX-315.00 Million ≈ $-38.33K	28.636x	+36611.36%
2022-12-31	GBX51.00 Million ≈ $6.21K	GBX-4.00 Million ≈ $-486.68	-0.078x	-104.51%
2021-12-31	GBX203.00 Million ≈ $24.70K	GBX353.00 Million ≈ $42.95K	1.739x	+173.88%
2020-12-31	GBX82.00 Million ≈ $9.98K	GBX-193.00 Million ≈ $-23.48K	-2.354x	-425.77%
2019-12-31	GBX209.00 Million ≈ $25.43K	GBX151.00 Million ≈ $18.37K	0.722x	-84.26%
2018-12-31	GBX66.00 Million ≈ $8.03K	GBX303.00 Million ≈ $36.87K	4.591x	+415.92%
2017-12-31	GBX-203.00 Million ≈ $-24.70K	GBX295.00 Million ≈ $35.89K	-1.453x	-5.33%
2016-12-31	GBX-295.00 Million ≈ $-35.89K	GBX407.00 Million ≈ $49.52K	-1.380x	-20.29%
2015-12-31	GBX-279.00 Million ≈ $-33.95K	GBX320.00 Million ≈ $38.93K	-1.147x	-23.82%
2014-12-31	GBX-475.00 Million ≈ $-57.79K	GBX440.00 Million ≈ $53.54K	-0.926x	+92.27%
2013-12-31	GBX-66.00 Million ≈ $-8.03K	GBX791.00 Million ≈ $96.24K	-11.985x	-300.67%
2012-12-31	GBX145.00 Million ≈ $17.64K	GBX866.00 Million ≈ $105.37K	5.972x	+112.17%
2011-12-31	GBX254.00 Million ≈ $30.90K	GBX715.00 Million ≈ $86.99K	2.815x	--

About Indivior PLC

LSE:INDV UK Drug Manufacturers - Specialty & Generic

Market Cap

$18.79 Million

GBX154.47 Billion GBX

Market Cap Rank

#25319 Global

#260 in UK

Share Price

GBX1238.00

Change (1 day)

+1.56%

52-Week Range

GBX986.00 - GBX1238.00

All Time High

GBX2481.00